Longitudinal change in basal ganglia volume in patients with Huntington's disease

Neurology

Volumn 48, Issue 2, 1997, Pages 394-399

  Aylward, Elizabeth H ^a   Li, Q ^a   Stine, O C ^a   Ranen, N ^a   Sherr, M ^a   Barta, P E ^a   Bylsma, F W ^a   Pearlson, G D ^a   Ross, C A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BASAL GANGLION; BRAIN ATROPHY; BRAIN SIZE; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLOBUS PALLIDUS; HUMAN; HUNTINGTON CHOREA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PRIORITY JOURNAL; PUTAMEN;

EID: 0031037349     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.48.2.394     Document Type: Article

References (35)

1. Meynert T. Diskussion zu fritsch. Psychiat-CbL 1877;47:7.
2. De La Monte SM, Vonsattel J, Richardson EP. Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease. J Neuropathol Exp Neurol 1988;47:516-525.
3. Myers RH, Vonsattel JP, Stevens TJ, et al. Clinical and neuropathologic assessment of severity in Huntington's disease. Neurology 1988;38:341-347.
4. Young A, Shoulson I, Penney J, et al. Huntington's disease in Venezuela: neurologic features and functional decline. Neurology 1986;36:244-249.
5. Myers RH, Sax DS, Koroshetz WJ, et al. Factors associated with slow progression in Huntington's disease. Arch Neurol 1991;48:800-804.
6. Currier RD, Jackson JF, Meydrech EF. Progression rate and age at onset are related in autosomal dominant neurologic diseases. Neurology 1982;32:907-909.
7. Myers RH, Sax DS, Schoenfeld M, et al. Late onset of Huntington's disease. J Neurol Neurosurg Psychiatry 1985;48: 530-534.
8. Feigin A, Kieburtz K, Bordwell K, et al. Functional decline in Huntington's disease. Mov Disord 1995;10:211-214.
9. Furtado S, Suchowersky O. Rewcastle N, Graham L, Klimek M, Garber A. Relationship between trinucleotide repeats and neuropathological changes in Huntington's disease. Ann Neurol 1996;39:132-136.
10. Illarioshkin S, Igarashi S, Onodera O, et al. Trinucleotide repeat length and rate of progression of Huntington's disease. Ann Neurol 1994;36:630-635.
11. Brandt J, Bylsma FW, Gross R, Stine OC, Ranen N, Ross CA. Trinucleotide repeat length and clinical progression in Huntington's disease. Neurology 1996;46:527-531.
12. Kieburtz K, MacDonald M, Shih C, et al. Trinucleotide repeat length and progression of illness in Huntington's disease. J Med Genet 1994;31:872-874.
13. Folstein SE, Leigh RR, Parhad IM, Folstein MF. The diagnosis of Huntington's disease. Neurology 1986;36:1279-1283.
14. Folstein SE. Huntington's disease: a disorder of families. Baltimore, MD: Johns Hopkins University Press, 1989.
15. Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993;72: 971-983.
16. Stine OC, Pleasant N, Franz ML, Abbott MH, Folstein SE, Ross CA. Correlation between the onset age of Huntington's disease and length of the trinucleotide repeat in IT-15. Hum Mol Genet 1993;2:1547-1549.
17. Folstein SE, Jensen B, Leigh RJ, Folstein M. The measurement of abnormal movement: methods developed for Huntington's disease. Neurobehav Toxicol Teratol 1983;5:605-609.
18. Aylward EH, Brandt J, Codori A, Mangus R, Barta P, Harris G. Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at-risk persons. Neurology 1994;44:823-828.
19. Starkstein S, Folstein S, Brandt J, Pearlson G, McDonnell A, Folstein M. Brain atrophy in Huntington's disease: a CT-scan study. Neuroradiology 1989;31:156-159.
20. Oepen G, Ostertag C. Diagnostic value of CT in patients with Huntington's chorea and their offspring. J Neurol 1981;225: 189-196.
21. Sax D, Menzer L. Computerized tomography in Huntington disease. Neurology 1977;27:388.
22. Masucci EF, Borts FT, Kurtzke JF. CT brainstem abnormalities in the differential diagnosis of Huntington's disease. Cornput Med Imaging Graph 1990;14:205-212.
23. Lang C. Is direct CT caudatometry superior to indirect parameters in confirming Huntington's disease? Neuroradiology 1985;27:161-163.
24. Bamford KA, Caine ED, Kido DK, Plassche WM, Shoulson I. Clinical-pathologic correlation in Huntington's disease: a neuropsychological and computed tomography study. Neurology 1989;39:796-801.
25. Bamford KA, Caine ED, Kido DK, Cox C, Shoulson I. A prospective evaluation of cognitive decline in early Huntington's disease: functional and radiographic correlates. Neurology 1995;45:1867-1873.
26. Starkstein S, Brandt J, Folstein S, et al. Neuropsychological and neuroradiological in Huntington's disease. J Neurol Neurosurg Psychiatry 1988;51:1259-1263.
27. Folstein M, Brandt J, Starkstein S. Cognition in Huntington's disease: characteristics and correlates. In: Franks A, Ironside J, Mindham R, Smith R, Spokes E, Winlow W, eds. Function and dysfunction in the basal ganglia. Manchester, England: Manchester University Press, 1990:224-229.
28. Sax D, O'Donnell B, Butters N, Menzer L, Montgomery K, Kayne H. Computerized tomographic, neurologic, and neuropsychological correlates of Huntington's disease. Int J Neurosci 1983;18:21-36.
29. 18FDG and computed tomographic scan. Ann Neurol 1982;12:425-434.
30. Starkstein SE, Brandt J, Bylsma F, Peyser C, Folstein M, Folstein SE. Neuropsychological correlates of brain atrophy in Huntington's disease: a magnetic resonance imaging study. Neuroradiology 1992;34:487-489.
31. Stober T, Wussow W, Schimrigk K. Bicaudate diameter - the most specific and simple CT parameter in the diagnosis of Huntington's disease. Neuroradiology 1984;26:25-28.
32. Neophytides A, DiChiro G, Barron S, Chase T. Computed axial tomography in Huntington's disease and persons at-risk for Huntington's disease. Adv Neurol 1979;23:185-191.
33. Harris GJ, Pearlson GD, Peyser CE, et al. Putamen volume reduction on magnetic resonance imaging exceeds caudate changes in mild Huntington's disease. Ann Neurol 1992;31: 69-75.
34. Aylward EH, Schwartz J, Machlin S, Pearlson G. Bicaudate ratio as a measure of caudate volume on MR images. AJNR Am J Neuroradiol 1991;12:1217-1222.
35. Ranen NG, Peyser CE, Coyle JT, et al. A controlled trial of idebenone in Huntington's disease. Mov Disord 1996;11: 549-554.